跳至主要内容
临床试验/DRKS00004826
DRKS00004826已完成未知

Influence of a written or oral patient information program in daily clinical practice on adherence and persistence with an aromatase inhibitor in adjuvant primary breast cancer treatment in comparison to standart clinical care within outcome research. - The COMPAS-Study

KGM, Phillips-Universität Marburg0 个研究点目标入组 181 人开始时间: 2013年3月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
181

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
one 至 one(—)
性别
Female

入选标准

  • Primary breast cancer
  • Aromatase inhibitor therapy following German breast cancer guidelines [30]
  • Informed consent
  • Patient is capable of using oral medication on her own initiative following prescribing information

排除标准

  • Continuously hospitalized, staying in nursery home or receive support via an ambulatory home care service or similar
  • Suffer from any form of dementia or similar disease with interference of memory
  • Other disease or mental or physical disorder that, in the opinion of the study coordinator, would interfere with participation in the study
  • Known medical, drug or alcohol abuse.

研究者

发起方
KGM, Phillips-Universität Marburg

相似试验